JP2014531436A5 - - Google Patents

Download PDF

Info

Publication number
JP2014531436A5
JP2014531436A5 JP2014529985A JP2014529985A JP2014531436A5 JP 2014531436 A5 JP2014531436 A5 JP 2014531436A5 JP 2014529985 A JP2014529985 A JP 2014529985A JP 2014529985 A JP2014529985 A JP 2014529985A JP 2014531436 A5 JP2014531436 A5 JP 2014531436A5
Authority
JP
Japan
Prior art keywords
atoms
cancer
hal
group
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014529985A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014531436A (ja
JP5964974B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/054900 external-priority patent/WO2013040059A1/en
Publication of JP2014531436A publication Critical patent/JP2014531436A/ja
Publication of JP2014531436A5 publication Critical patent/JP2014531436A5/ja
Application granted granted Critical
Publication of JP5964974B2 publication Critical patent/JP5964974B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014529985A 2011-09-12 2012-09-12 キナーゼ活性のモジュレーターとしての新規イミダゾールアミン Expired - Fee Related JP5964974B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161533601P 2011-09-12 2011-09-12
US61/533,601 2011-09-12
PCT/US2012/054900 WO2013040059A1 (en) 2011-09-12 2012-09-12 Novel imidazole amines as modulators of kinase activity

Publications (3)

Publication Number Publication Date
JP2014531436A JP2014531436A (ja) 2014-11-27
JP2014531436A5 true JP2014531436A5 (enExample) 2016-06-09
JP5964974B2 JP5964974B2 (ja) 2016-08-03

Family

ID=46881179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014529985A Expired - Fee Related JP5964974B2 (ja) 2011-09-12 2012-09-12 キナーゼ活性のモジュレーターとしての新規イミダゾールアミン

Country Status (24)

Country Link
US (2) US9145392B2 (enExample)
EP (1) EP2755965B1 (enExample)
JP (1) JP5964974B2 (enExample)
KR (1) KR101995605B1 (enExample)
CN (1) CN104080782B (enExample)
AU (1) AU2012308696B2 (enExample)
BR (1) BR112014005554A2 (enExample)
CA (1) CA2844830C (enExample)
DK (1) DK2755965T3 (enExample)
EA (1) EA025098B1 (enExample)
ES (1) ES2644536T3 (enExample)
HR (1) HRP20171554T1 (enExample)
HU (1) HUE035019T2 (enExample)
IL (1) IL231383A (enExample)
LT (1) LT2755965T (enExample)
MX (1) MX346095B (enExample)
NO (1) NO2791461T3 (enExample)
PL (1) PL2755965T3 (enExample)
PT (1) PT2755965T (enExample)
RS (1) RS56534B1 (enExample)
SG (2) SG2014009278A (enExample)
SI (1) SI2755965T1 (enExample)
WO (1) WO2013040059A1 (enExample)
ZA (1) ZA201401013B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9321760B2 (en) * 2011-09-12 2016-04-26 Merck Patent Gmbh Aminopyrimidine derivatives for use as modulators of kinase activity
HK1211027A1 (en) 2012-10-16 2016-05-13 Almirall, S.A. Pyrrolotriazinone derivatives as pi3k inhibitors
EP2920154B1 (en) 2012-11-16 2017-10-11 Merck Patent GmbH Novel imidazol-piperidinyl derivatives as modulators of kinase activity
AR095202A1 (es) * 2013-03-11 2015-09-30 Merck Patent Gmbh Heterociclos como moduladores de la actividad quinasa
MX2016010268A (es) * 2014-02-11 2016-10-13 Merck Patent Gmbh Pirimidinimidazolaminas como modulares de actividad de cinasa.
JP6529085B2 (ja) 2014-04-18 2019-06-12 武田薬品工業株式会社 複素環化合物
CN109467538A (zh) 2017-09-07 2019-03-15 和记黄埔医药(上海)有限公司 环烯烃取代的杂芳环类化合物及其用途
KR20200093159A (ko) 2019-01-28 2020-08-05 주식회사 링크모션 스마트 팜 모듈 구조물
BR112022010924A2 (pt) 2019-12-06 2022-09-06 Vertex Pharma Tetra-hidrofuranos substituídos como moduladores de canais de sódio
US11866421B2 (en) 2021-05-31 2024-01-09 Epigen Biosciences, Inc. Pyrimidine and pyridine amine compounds and usage thereof in disease treatment
SMT202500481T1 (it) 2021-06-04 2026-01-12 Vertex Pharma N-(idrossialchil(etero)aril)tetraidrofuran carbossammidi come modulatori di canali del sodio
CN117567435A (zh) * 2022-01-30 2024-02-20 上海市第十人民医院 谷氨酰胺环化酶抑制剂及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
AU2004230841A1 (en) 2003-04-03 2004-10-28 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
EP1670771A4 (en) 2003-09-30 2010-09-01 Irm Llc COMPOUNDS AND COMPOSITIONS INHIBITING PROTEIN-KINASES
WO2005039506A2 (en) 2003-10-24 2005-05-06 Exelixis, Inc. P70s6 kinase modulators and method of use
PT1687305E (pt) 2003-11-21 2008-10-17 Novartis Ag Derivados de 1h-imidazoquinolina como inibidores de proteína quinase
ATE447957T1 (de) 2003-12-09 2009-11-15 Us Gov Health & Human Serv Verfahren zur unterdrückung einer immunantwort oder zur behandlung von proliferativen erkrankungen
WO2005117909A2 (en) 2004-04-23 2005-12-15 Exelixis, Inc. Kinase modulators and methods of use
JP5274842B2 (ja) 2004-12-28 2013-08-28 エグゼリクシス, インコーポレイテッド 免疫疾患、炎症疾患および増殖疾患の処置のためのセリン−スレオニンキナーゼモジュレーター(p70S6K、Akt−1およびAkt−2)としての[1H−ピペラゾ[3,4−d]ピリミジン−4−イル]−ピペラジンまたは[1H−ピペラゾ[3,4−d]ピリミジン−4−イル]−ピペラジン化合物
WO2006078992A2 (en) * 2005-01-19 2006-07-27 Neurogen Corporation Heteroaryl substituted piperazinyl-pyridine analogues
GB0501999D0 (en) 2005-02-01 2005-03-09 Sentinel Oncology Ltd Pharmaceutical compounds
US8343953B2 (en) 2005-06-22 2013-01-01 Astex Therapeutics Limited Pharmaceutical compounds
AR064416A1 (es) * 2006-12-21 2009-04-01 Cancer Rec Tech Ltd Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas.
UA99284C2 (ru) * 2007-05-11 2012-08-10 Елі Ліллі Енд Компані ИНГИБИТОРЫ р70 S6-КИНАЗЫ
AR074072A1 (es) 2008-11-11 2010-12-22 Lilly Co Eli Compuesto de imidazol -piperidin -pirrol-pirimidin-6-ona, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar el glioblastoma multiforme
SI2396307T1 (sl) 2009-02-11 2015-02-27 Merck Patent Gmbh Novi amino azaheterockliäśni karboksamidi
UA110113C2 (xx) 2010-07-29 2015-11-25 Біциклічні азагетероциклічні карбоксаміди
AU2011282684B2 (en) 2010-07-29 2015-05-21 Merck Patent Gmbh Cyclic amine azaheterocyclic carboxamides
LT2643313T (lt) 2010-11-24 2016-10-25 Merck Patent Gmbh Chinazolino karboksamido azetidinai

Similar Documents

Publication Publication Date Title
JP2014531436A5 (enExample)
JP2014527082A5 (enExample)
JP2022520811A5 (enExample)
JP2022520448A5 (enExample)
JP2019533694A5 (enExample)
JP6078639B2 (ja) Abl1、abl2およびbcr−abl1の活性を阻害するためのベンズアミド誘導体
IL295799A (en) Trophomyosin receptor kinase (trk) degradation compounds and methods of use
HRP20171554T1 (hr) Novi imidazol amini kao modulatori aktivnosti kinaze
JP2017510555A5 (enExample)
JP2017510554A5 (enExample)
JP2023514872A5 (enExample)
JP2015526519A5 (enExample)
JP2008528467A5 (enExample)
JP2013523814A5 (enExample)
JP2016525076A5 (enExample)
WO2013115280A1 (ja) ピリドン誘導体
JP2016513660A5 (enExample)
JP2016527238A5 (enExample)
JP2009542608A5 (enExample)
JP2018515492A5 (enExample)
JP2013525356A5 (enExample)
RU2011153788A (ru) Гетероциклические противовирусные соединения
HRP20171655T1 (hr) Derivati aminopirimidina za upotrebu kao modulatori aktivnosti kinaze
RU2017118165A (ru) Ингибиторы энхансера гомолога 2 zestes
RU2018131775A (ru) 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета